Related Experiment Video

Updated: Jul 23, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

The Comparative Effectiveness of Ciprofloxacin and Metronidazole for an Initial Episode of Pouchitis: A

Edward L Barnes1,2,3, Aakash Desai4, Gursimran S Kochhar5

  • 1Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

The American Journal of Gastroenterology
|July 18, 2023
PubMed
Abstract

Insights

For initial pouchitis treatment after ulcerative colitis surgery, ciprofloxacin, metronidazole, and combination therapy showed similar effectiveness. This study found no significant difference in preventing pouchitis recurrence between these common antibiotic regimens.

Area of Science:

  • Gastroenterology
  • Clinical Pharmacology
  • Surgical Outcomes

Background:

  • Pouchitis is a common complication following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC).
  • Evidence comparing individual antibiotic treatments for initial pouchitis episodes is limited.
  • Optimal antibiotic selection for pouchitis remains an area of clinical uncertainty.

Purpose of the Study:

  • To compare the real-world effectiveness of ciprofloxacin monotherapy, metronidazole monotherapy, and combination therapy (ciprofloxacin and metronidazole) for initial pouchitis episodes.
  • To evaluate the impact of these antibiotic regimens on early treatment failure and pouchitis recurrence within 12 months.

Main Methods:

  • Retrospective cohort study utilizing the TriNetX electronic health records network.
  • Inclusion of patients with pouchitis post-IPAA for UC treated with ciprofloxacin, metronidazole, or combination therapy.
  • Propensity score matching to control for demographic and clinical confounders, including age, sex, race, PSC, smoking, obesity, and anti-TNF exposure.

Main Results:

  • Among 271 patients, 70% experienced recurrent pouchitis.
  • No statistically significant difference in the odds of early relapse or nonresponse was observed between ciprofloxacin and metronidazole monotherapy.
  • Comparison of monotherapy regimens against combination therapy also revealed no significant differences in pouchitis recurrence rates.

Conclusions:

  • This study found no significant difference in the real-world effectiveness of ciprofloxacin, metronidazole, or combination therapy for the initial treatment of pouchitis.
  • Antibiotic choice among these options may not impact short-term outcomes for initial pouchitis episodes.
  • Further research may be needed to identify factors influencing treatment response in pouchitis.

More Related Videos

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

409
Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection05:32

Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection

Published on: September 21, 2015

32.3K

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
160
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
461
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
15
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
217
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
219
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
175